California’s Board of Pharmacy (BOP) has been mulling a proposal to restrict access to what are called “category one sterile compounds.”

Targeted elements include glutathione, vitamin B12, and other substances often relied on by Lyme patients and others who are chronically ill, as well as by firefighters who have been exposed to toxins on the job.

After a contentious meeting on July 31, the board put off the decision until the September 12 meeting.

At the September 12 meeting, some two dozen members of the public spoke against the proposal. Many of the speakers identified themselves as having chronic Lyme disease. Some took part in the Sacramento meeting in person, though most gave their comments remotely, via WebEx.

After the public had spoken, two different motions related to the issue failed to pass. The board will revisit the proposal at its next meeting, November 6-7.

Crystal Frost, a Lyme patient who co-founded the STOP THE BOP movement, says her group will not let up on its efforts to prevent the board from taking this drastic step. Sign their petition here.

She spoke with Fox 11 Los Angeles after the board’s latest action.

See Crystal Frost’s earlier blog on the subject here:

Fighting to save our lifeline of glutathione, B12, and more

See her summary of the Sept. 12 meeting here.

Visit the Stop The BOP website here.